Asepsis is a medical device company specializing in the delivery enhancement of oral and parenteral medicinal solutions. Our core competence focuses on personalized dosed products that increase patient outcome and medication efficacy, by providing higher precision adherence to the established optimal clinical dosing. The Asepsis portfolio enhances convenience and safety by providing health care professionals with intuitive delivery apparatus that simplify administration by the elimination of crucial user sequences. Our technology provides proprietary clinical and non-clinical enhancements that create innovative differentiated products, while in parallel continuing to conform to a medications original safety and efficacy profile. Asepsis is dedicated to improving critical caregiver procedures and enhancing patient outcomes, through providing proprietary platforms that enable medications to be intuitively prepared and administered at the highest possible precision. We are committed to transforming pediatric and personized dosed medicine to a higher standard of care by providing products that deliver medications precisely to their optimal therapeutic dose. Our portfolio can enhance patient outcomes across a broad range of medications in commercial use, and in most cases without any clinical trials or prior authorization required. Additionally, this personalized optimal dosing platform used within early drug trials, may also improve efficacy and/or reduce toxicity to individualized patients, thus potentially increasing the overall success of the drug candidate.